Here are the latest updates on the approval and upcoming sales of Presvu Eye Drops:
- Government Approval: The Drug Controller General of India (DCGI) has approved Presvu Eye Drops, developed by Entod Pharmaceuticals.
- Vision Improvement: These eye drops can improve vision within 15 minutes of application.
- Sales Launch: Presvu Eye Drops will be available for sale starting next month.
- Target Condition: The eye drops are designed to treat presbyopia, a common age-related vision problem.
- Market Impact: This approval marks a significant advancement in eye care innovation in India.
- Usage Benefits: Presvu Eye Drops aim to reduce the reliance on reading glasses for individuals with presbyopia.
- Product Availability: The eye drops will be launched in the domestic market in the first week of October.
- Global Reach: Entod Pharmaceuticals plans to expand the product to emerging markets such as Africa and Southeast Asia.
- Cost: The eye drops will be available at a cost of Rs 350 per bottle.
- Expert Opinion: Dr. Aditya Sethi highlighted that Presvu Eye Drops can significantly improve near vision, enhancing the quality of life for many.
-
Gold and silver rates today: Latest Rates in all Major Cities February 7, 2026
Gold and silver have been integral to Indian culture and investment portfolios for centuries. Whether you’re planning to
-
Tata Steel Q3 FY26 Breakdown: 723% YoY PAT Growth to Rs 2,689 Cr Despite Global Headwinds
Tata Steel’s Q3 PAT explodes 723% to Rs 2,689 crore—highest ever! How did record India production crush global
-
How Budget 2026 Makes TDS&TCS Rules Mandatory for Deductors and Officers Starting 1st April 2026
Budget 2026 Twist: TDS/TCS guidelines now BIND tax officers—deductors finally WIN! Imagine dodging penalties & disputes overnight from
-
Crypto tax reporting just got tougher: Rs 200 daily penalty for Section 509 failures
Budget 2026: Miss a transaction report, and exchanges pay Rs 200 per day starting April! But wait—who’s really in the crosshairs? Investors,
-
LIC Q3 FY26 net profit surges 17.46% to ₹12,930 crore: How this boosts security for 25 crore policyholders
LIC’s Q3 profit explodes 17% to ₹12,930 Cr – shares skyrocket 7.7% in 9 months’ biggest surge! But
-
Sapphire Foods Q3 FY26 Loss: How New Labour Codes Are Squeezing KFC India Profits and Stock Returns
KFC India’s powerhouse Sapphire Foods suddenly plunged into a shocking ₹4.8 Cr Q3 loss—despite booming revenue! What’s behind





